Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

38
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
38

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

When minds and networks matter: how mental health and social capital shape social frailty in older adults.

Frontiers in medicine·2026
Same author

Occupational hazard awareness and safety-related knowledge among EMS students: evidence of a potential gap.

Scientific reports·2026
Same author

Corrigendum to "LLM predicts human behavior: A BERT-based approach for conscientiousness personality trait detection from online content" [Acta Psychologica 266 (2026), 106832].

Acta psychologica·2026
Same author

RETRACTED: Arslan et al. CAVVPM: Challenge-Based Authentication and Verification of Vehicle Platooning at Motorway. <i>Sensors</i> 2022, <i>22</i>, 7946.

Sensors (Basel, Switzerland)·2026
Same author

Evaluation of Video-Based Instruction and a 360° Virtual Reality Module on Personal Protective Equipment Competency and Infection Prevention in Healthcare Settings: A Quasi-Experimental Study.

Healthcare (Basel, Switzerland)·2026
Same author

Immune and non-immune hydrops fetalis in a Saudi tertiary center: etiologies, antenatal predictors, perinatal outcomes, and one-year survival in a seven-year cohort.

Frontiers in pediatrics·2026
Same journal

Revolutionizing Transcriptomics: From Single-Cell Insights to RNA-based Interventions.

SLAS technology·2026
Same journal

Smartphone-based colorimetric glucose biosensor using peroxidase-like activity of bimetallic catalyst supported onto graphitic carbon nitride nanosheets.

SLAS technology·2026
Same journal

XVCF: Exquisite visualization of VCF data from genomic experiments.

SLAS technology·2026
Same journal

EasyPip: An equipment-agnostic software application to transform automated liquid handlers into efficient walk-up tools for routine plate-based pipetting.

SLAS technology·2026
Same journal

Identification of ubiquitination-related biomarkers in osteoarthritis: Combining transcriptome and Mendelian randomization analysis.

SLAS technology·2026
Same journal

Miniaturization of a Lumit p-ERK immunoassay for cell-based high-throughput screening of a chemogenetic small-molecule library.

SLAS technology·2026
See all related articles

Related Experiment Video

Updated: May 7, 2026

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

12.1K

Robot-based solution for helping Alzheimer patients.

Mohammed Faisal1, Abdullah Alharbi2, Amnah Alhamadi1

  • 1Department of Computer Science & Engineering, Faculty of Engineering, Kuwait College of Science and Technology (KCST), Kuwait.

SLAS Technology
|May 10, 2024
PubMed
Summary
This summary is machine-generated.

This study introduces the Alzheimer Care Companion Robot (ACCR), a novel social robot designed to support Alzheimer's patients. The ACCR uses conversation and personalized media to improve cognitive function and emotional well-being.

Keywords:
Artificial intelligence, Alzheimer care companion robot, Kuwait dialectRobotics

More Related Videos

Author Spotlight: Enhancing Post-Stroke Upper Limb Rehabilitation with Robotic Technologies for Improved Motor Recovery and Functional Outcomes
04:49

Author Spotlight: Enhancing Post-Stroke Upper Limb Rehabilitation with Robotic Technologies for Improved Motor Recovery and Functional Outcomes

Published on: September 6, 2024

725
Brain-Computer Interface-controlled Upper Limb Robotic System for Enhancing Daily Activities in Stroke Patients
06:11

Brain-Computer Interface-controlled Upper Limb Robotic System for Enhancing Daily Activities in Stroke Patients

Published on: April 18, 2025

335

Related Experiment Videos

Last Updated: May 7, 2026

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

12.1K
Author Spotlight: Enhancing Post-Stroke Upper Limb Rehabilitation with Robotic Technologies for Improved Motor Recovery and Functional Outcomes
04:49

Author Spotlight: Enhancing Post-Stroke Upper Limb Rehabilitation with Robotic Technologies for Improved Motor Recovery and Functional Outcomes

Published on: September 6, 2024

725
Brain-Computer Interface-controlled Upper Limb Robotic System for Enhancing Daily Activities in Stroke Patients
06:11

Brain-Computer Interface-controlled Upper Limb Robotic System for Enhancing Daily Activities in Stroke Patients

Published on: April 18, 2025

335

Area of Science:

  • Neurology
  • Human-Computer Interaction
  • Robotics

Background:

  • Alzheimer's disease is a progressive neurological disorder causing cognitive decline and memory loss.
  • It presents significant challenges for patients, families, and healthcare systems.
  • Enhancing the quality of life for Alzheimer's patients is a key societal goal.

Purpose of the Study:

  • To explore the potential of social robots in providing emotional support to Alzheimer's patients.
  • To improve cognitive function and facilitate communication in individuals with Alzheimer's disease.
  • To introduce a novel framework and a specific robot, the Alzheimer Care Companion Robot (ACCR), for Alzheimer's care.

Main Methods:

  • Development of the Alzheimer Care Companion Robot (ACCR) with a framework for building Alzheimer's care robots.
  • The ACCR is designed to identify Alzheimer's patients and initiate conversations in the Arab-Kuwaiti dialect.
  • Incorporation of 271 conversations (active, proactive, GUI) and display of personalized memories (images, videos) to aid recall.

Main Results:

  • The experimental results demonstrated the successful implementation and effectiveness of the proposed ACCR solution.
  • The ACCR successfully initiated conversations and displayed relevant memories to assist patients.
  • The study validated the proposed framework for developing specialized care robots.

Conclusions:

  • Social robots like the ACCR show promise in supporting Alzheimer's patients by offering emotional and cognitive assistance.
  • The ACCR's conversational approach and personalized memory recall feature can enhance patient well-being.
  • This research contributes a novel framework and a functional prototype for advancing robotic care solutions in neurodegenerative diseases.